Researchers report on the BRIGHT AML 1019 Phase III trial.
Researchers explore the predictive capability of EVI1 expression.
Researchers look at how mutation status can influence responses to targeted therapy in thyroid cancer.
COX7RP contributes to endometrial and breast cancer growth.
Diagnosis of endometrial carcinoma made easier by analysis of mutations in cervix or endometrial tissue.
The Global Burden of Disease 2017 study found non-melanoma skin cancer to be the biggest increase in incidence worldwide.
Investigators assessed effects of TIB on cell number, migration, invasion, estrogen, and progesterone receptor activity and content.
Many clinical trials in breast and endometrial cancers are underway and recruiting patients.
A new study looked at median overall survival for patients with prior antibiotic therapy compared with patients with no prior antibiotic therapy.
Age disparities in oncology trials are continuing, despite opposition to this issue.